← CYTOKINETICS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $106.4m |
$13.4m
-87.44%
|
$31.5m
+135.64%
|
$26.9m
-14.71%
|
$55.8m
+107.79%
|
$70.4m
+26.15%
|
$94.6m
+34.30%
|
$7.5m
-92.04%
|
$18.5m
+145.34%
|
$88.0m
+376.56%
|
$67.7m
-23.14%
|
|
| Research and Development Expense | $59.9m | $90.3m | $89.1m | $86.1m | $97.0m | $159.9m | $240.8m | $330.1m | $339.4m | $416.0m | $401.0m | |
| General and Administrative Expense | $27.8m | $36.5m | $31.3m | $39.6m | $52.8m | $96.8m | $178.0m | $173.6m | $215.3m | $284.3m | $242.1m | |
| Operating Lease, Expense | — | — | — | $5.1m | $5.7m | — | — | — | — | — | — | |
| Operating Expenses | $87.7m | $126.8m | $120.4m | $125.7m | $149.8m | $256.7m | $418.8m | $503.7m | $554.7m | $700.3m | $771.4m | |
| Operating Income (Loss) | $18.7m |
($113.4m)
-706.82%
|
($88.9m)
+21.59%
|
($98.9m)
-11.19%
|
($93.9m)
+4.98%
|
($186.3m)
-98.33%
|
($324.2m)
-74.01%
|
($496.2m)
-53.05%
|
($536.2m)
-8.07%
|
($612.3m)
-14.17%
|
($707.9m)
-15.62%
|
|
| Interest Expense | $2.7m | $3.0m | $3.8m | $6.6m | $16.0m | $16.4m | $19.4m | $28.3m | $37.7m | $45.6m | $124.8m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $16.5m | ($127.2m) | ($106.3m) | — | — | — | — | — | — | — | ($894.0m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $16.5m | ($127.8m) | ($106.3m) | — | — | — | — | — | — | — | ($894.0m) | |
| Income Tax Expense (Benefit) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income (Loss) Attributable to Parent | $16.5m |
($127.8m)
-876.70%
|
($106.3m)
+16.83%
|
($121.7m)
-14.49%
|
($127.3m)
-4.60%
|
($215.3m)
-69.15%
|
($389.0m)
-80.65%
|
($526.2m)
-35.30%
|
($589.5m)
-12.03%
|
($785.0m)
-33.15%
|
($894.0m)
-13.89%
|
|
| Earnings Per Share, Basic | $0.41 | ($2.59) | — | — | — | — | ($4.33) | ($5.45) | ($5.26) | ($6.54) | ($7.22) | |
| Earnings Per Share, Diluted | $0.39 | ($2.59) | — | — | — | — | ($4.33) | ($5.45) | ($5.26) | ($6.54) | ($7.22) | |
| Weighted Average Number of Shares Outstanding, Basic | 39.9m | 49.4m | — | — | — | — | 90k | 97k | 112k | 120k | 124.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | 42.6m | 49.4m | — | — | — | — | 90k | 97k | 112k | 120k | 124.5m | |
| Additional Financial Items | ||||||||||||
| Realized Investment Gains (Losses) | — | — | — | — | — | — | — | — | $19k | $25k | — |